Altered gene expression in human leukemia K562 cells selected for resistance to etoposide
References (87)
Biochemical basis for the interaction of type I and type II topoisomerases with DNA
Pharmacol Ther
(1989)Eukaryotic topoisomerase II. Characterization of enzyme turnover
J Biol Chem
(1986)- et al.
Transcription generates positively and negatively supercoiled domains in the template
Cell
(1988) Nuclear protooncogene products: Finetuned components of signal transduction pathways
Cell Signal
(1990)- et al.
Early response gene induction following DNA damage in astrocytoma cell lines
Biochem Pharmacol
(1993) - et al.
Characterization of an amsacrine-resistant line of human leukemia cells: Evidence for a drug-resistant form of topoisomerase II
J Biol Chem
(1989) - et al.
Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II
J Mol Biol
(1992) - et al.
Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line
J Biol Chem
(1993) - et al.
Cloning and characterization of the 5′-flanking region of the human topoisomerase IIα gene
J Biol Chem
(1992) - et al.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Anal Biochem
(1987)
Ellipticine-induced protein-associated DNA breaks in isolated L1210 nuclei
Biochim Biophys Acta
(1982)
Unstable β-globin mRNA in mRNA deficient β° thalassemia
Cell
(1981)
Autoregulation of tubulin expression is achieved through specific degradation of polysomal tubulin mRNAs
Cell
(1987)
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
Cell
(1983)
Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemia cells
J Biol Chem
(1990)
The c-fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes
Cell
(1988)
The jun proto-oncogene is positively autoregulated by its product, jun/AP-1
Cell
(1988)
DNA topoisomerases
Annu Rev Biochem
(1985)
DNA topoisomerase poisons as antitumor drugs
Annu Rev Biochem
(1989)
Topoisomerase IIα and topoisomerase IIβ genes: Characterization and mapping to human chromosomes 17 and 3, respectively
Cancer Res
(1992)
Topoisomerase II levels during granulocytic maturation in vitro and in vivo
Cancer Res
(1991)
Topoisomerase IIα and β in human tumor cells grown in vitro and in vivo
Anticancer Res
(1992)
Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: Evidence for an active enzyme-cleaved DNA intermediate
Biochemistry
(1990)
Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells
Nature
(1986)
Roles of DNA topoisomerase in simian virus 40 DNA replication in vitro
Transcription of DNA injected into Xenopus oocytes is influenced by template topology
Nature
(1983)
Supercoiling of the DNA template during transcription
DNA topoisomerase II is required for formation of mitotic chromosomes in Chinese hamster ovary cells: Studies using the inhibitor
Biochemistry
(1990)
Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells
Cancer Res
(1987)
Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells
Cancer Res
(1987)
Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle
Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells
Cancer Res
(1988)
Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase activity
Cancer Res
(1989)
Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation
Cancer Res
(1990)
Topoisomerase inhibitors have potent differentiation-inducing activity for human and mouse myeloid leukemia cells
Jpn J Cancer Res
(1991)
Correlation between the DNA-binding affinity of topoisomerase inhibiting drugs and their ability to induce hematopoietic cell differentiation
Toxicol Lett
(1993)
Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II
Cancer Res
(1990)
Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: Induction of vimentin gene expression
Mol Pharmacol
(1991)
Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170 kD and 180 kD forms of topoisomerase II
Cancer Res
(1990)
Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells
Cancer Res
(1991)
Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide
Mol Pharmacol
(1991)
DNA topoisomerase II cleaves at specific sites in the 5′ flanking region of c-fos proto-oncogenes in vitro
EMBO J
(1986)
In vivo and in vitro stimulation by antitumor drugs of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene
Natl Cancer Inst Monogr
(1987)
Cited by (0)
Copyright © 1993 Published by Elsevier Inc.